Skip to main content
. 2015 May 27;9:943–952. doi: 10.2147/OPTH.S82398

Table 2.

10-2 Visual field outcomes

Characteristic 10-2 VF with III, white test object
No retinopathy Retinopathy P-value
Number of scotoma locations 22 (17, 34) 46 (36, 52) 0.0003*
Number of scotoma points 25 (19, 52) 119 (71, 219) 0.0005*
Ratio of number of scotoma locations to scotoma points (%) 80 (66, 90) 38 (27, 56) 0.0025*
Average number of scotoma points per VF 5 (3, 8) 25 (15, 37) 0.0004*
Percentage of scotoma points that resolved 86 (63, 100) 22 (10, 59) 0.0009*
Percentage of persistent scotoma points 16 (0, 37) 78 (41, 90) 0.0009*
Percentage of low-risk scotoma points 40 (25, 46) 21 (15, 32) 0.0094*
Percentage of high-risk scotoma points 60 (54, 75) 79 (68, 85) 0.0094*
Number of persistent scotoma locations at last visit 0 (0, 2) 28 (7, 33) 0.0003*
Percentage of 1-point scotomas 64 (51, 76) 31 (11, 50) 0.0007*
Percentage of 2-point scotomas 16 (7, 27) 7 (0, 21) 0.2962
Percentage of 3-point scotomas 0 (0, 7) 0 (0, 12) 0.9447
Percentage of 4-point scotomas 3 (0, 8) 0 (0, 2) 0.1040
Percentage of larger than 4-point scotomas 2 (0, 18) 42 (21, 89) 0.0004*
Percentage of scotoma points in superonasal quadrant 17 (5, 31) 29 (23, 36) 0.0212*
Percentage of scotoma points in superotemporal quadrant 25 (12, 32) 28 (25, 31) 0.3417
Percentage of scotoma points in inferonasal quadrant 22 (17, 30) 19 (16, 22) 0.3002
Percentage of scotoma points in inferotemporal quadrant 37 (23, 47) 24 (16, 30) 0.0328*
Percentage of persistent scotoma points deepening by one step 1 (0, 11) 7 (3, 9) 0.2069
Percentage of persistent scotoma points deepening by two steps 0 (0, 1) 2 (1, 4) 0.0103*
Percentage of persistent scotoma points shallowing by one step 4 (0, 25) 2 (0, 5) 0.6723
Percentage of persistent scotoma points shallowing by two steps 0 (0, 0) 0 (0, 4) 0.2154

Notes: P-values refer to the Kruskal–Wallis test.

*

Statistically significant. Data in the table are presented as medians followed by the interquartile range.

Abbreviation: VF, visual field.